The disclosed technology relates to intravascular diagnosis. More particularly, the disclosed technology relates to diagnosing the severity of stenosis in the vasculature of a patient.
Reduced blood flow due to atherosclerotic occlusion of vessels is a major cause of vascular diseases. Pressure measurements in arterial vessels and particularly in coronary arteries prior to treatment have been used for lesion characterization and treatment selection. More specifically, pressure gradient across a lesion has been clinically used as an indicator for lesion severity. Measurements made during and after treatment allow one to assess therapy efficacy. Existing equipment for monitoring intravascular measurements have multiple, separate parts and bulky monitors. There is, accordingly, continuing interest in improved monitoring equipment.
The disclosed technology relates to diagnosing the severity of stenoses in the vasculature of a patient.
In one aspect of the disclosed technology, an apparatus for intravascular diagnosis includes a monitoring guidewire having a core wire and a sensor disposed in a distal region of the core wire, and a portable display unit configured to be disposed after a predetermined number of uses or after a predetermined duration of use. The portable display unit can include a processor and a display screen, where the portable display unit is capable of receiving communication from the monitoring guidewire, is configured to perform computations using the processor based on communications received from the monitoring guidewire, and is configured to display information on the display screen based on the computations.
In one embodiment, the portable display unit includes one or more batteries configured to power the portable display unit. In one embodiment, the one or more batteries can be rechargeable by a power source of the portable display unit and/or a power source external to the portable display unit.
In one embodiment, the portable display unit further includes one or more batteries configured to power the portable display unit for a predetermined duration of use, such that the portable display unit can be configured to be disposed after the one or more batteries are depleted. In one embodiment, the one or more batteries are non-rechargeable. In one embodiment, the portable display unit can be configured to be inoperable after a one uses.
In one aspect of the disclosed technology, the monitoring guidewire can be configured to be disposed after a single use.
In one embodiment, the portable display unit and the monitoring guidewire can communicate wirelessly. In one embodiment, the portable display unit includes a connector configured to establish a communicative connection with the monitoring guidewire. In one embodiment, the connector is configured to establish a mechanical connection with the monitoring guidewire to control the guidewire within a vasculature. In one embodiment, a torquer is configured to engage the monitoring guidewire to control the guidewire within a vasculature.
In one embodiment, the monitoring guidewire includes a housing surrounding the sensor, and the housing can be laser etched to provide flexibility for the housing. In one embodiment, the monitoring guidewire includes a flexible coil surrounding the sensor, with the coil having a relaxed portion over the sensor.
In one aspect of the disclosed technology, the sensor is a pressure sensor and communication from the monitoring guidewire includes measurements from the pressure sensor. The processor of the portable display unit is capable of computing fractional flow reserve based on pressure measurements from only the pressure sensor in the distal region of the core wire.
In one embodiment, the fractional flow reserve is a push-forward fraction flow reserve (“FFR”) computed as: FFR=(Psensor−Pra)/(Psaved−Pra), where:
Psaved are moving means over time of recorded pressure measurements proximal to a first stenosis,
Psensor are moving means over time of real time pressure measurements distal to the first stenosis, and
Pra is a constant.
In one embodiment, Psaved are moving means over time of recorded pressure measurements proximal to the first stenosis and proximal to a second stenosis. In one embodiment, Psensor are moving means over time of real time pressure measurements distal to the first stenosis and proximal to a second stenosis. In one embodiment, Psensor moving means over time of real time pressure measurements distal to the first stenosis and distal to the second stenosis.
In one embodiment, the fractional flow reserve is a pull-back fraction flow reserve computed as: FFR=(Psaved−)/(Psensor−Pra), where:
Psaved are moving means over time of recorded pressure measurements distal to a first stenosis,
Psensor are moving means over time of real time pressure measurements proximal to the first stenosis, and
Pra is a constant.
In one embodiment, Psensor are moving means over time of real time pressure measurements proximal to the first stenosis and distal to a second stenosis. In one embodiment, Psaved are moving means over time of recorded pressure measurements distal to the first stenosis and distal to a second stenosis. In one embodiment, Psensor are moving means over time of real time pressure measurements proximal to the first stenosis and proximal to the second stenosis.
In one embodiment, the portable display unit displays on the display screen the fractional flow reserve. In one embodiment, the portable display unit displays a graph of the pressure measurements.
In one embodiment, the portable display unit includes a communications port configured to receive communications that include pressure measurements.
In one embodiment, the fractional flow reserve is a pull-back fraction flow reserve computed as: FFR=(Psensor−Pra)/(Pport−Pra), where:
Pport are moving means over time of real-time pressure measurements received at the communications port,
Psensor are moving means over time of real-time pressure measurements from the pressure sensor disposed in the distal region of the core wire, and
Pra is a constant.
In one embodiment, the portable display unit is configured with capability to compute fractional flow reserve in at least two ways: computing fractional flow reserve based on pressure measurements from only the pressure sensor disposed in the distal region of the core wire, and computing fractional flow reserve based on the pressure measurements from the pressure sensor and based on pressure measurements received at a communications port. In one embodiment, the portable display unit can be configured to automatically use one of the at least two ways of computing fractional flow reserve. In one embodiment, the portable display unit can be configured to automatically select one of the ways of computing fractional flow reserve when a condition is present and can be configured to automatically select another of the at least two ways of computing fractional flow reserve when the condition is absent. In one embodiment, the portable display unit can be configured to permit a user to manually select one of the at least two ways of computing fraction flow reserve.
In one aspect of the disclosed technology, an apparatus for intravascular diagnosis includes a monitoring guidewire having a core wire and a sensor disposed in a distal region of the core wire, and a handheld display unit configured to be disposed after a predetermined number of uses or after a predetermined duration of use. The handheld display unit can include a processor and a display screen, where the handheld display unit is capable of receiving communication from the monitoring guidewire, is configured to perform computations using the processor based on communications received from the monitoring guidewire, and is configured to display information on the display screen based on the computations. In one embodiment, the handheld display unit can be equal to or less than 30 cm×30 cm×30 cm in size.
In one aspect of the disclosed technology, an apparatus for intravascular diagnosis includes a monitoring guidewire having a core wire and a sensor disposed in a distal region of the core wire, and a portable display unit capable of receiving communication from the monitoring guidewire. The portable display unit includes a processor and display screen, and is configured to perform computations using the processor based on communications received from the monitoring guidewire and is configured to display information on the display screen based on the computations. The portable display unit has no capability of being turned off after the display screen is turned on,
These aspects and embodiments of the disclosed technology are exemplary and do not limit the scope of the disclosed technology, which will be apparent from a reading of the following detailed description and the associated drawings.
The disclosed technology relates to diagnosing the severity of stenosis in the vasculature of a patient. The disclosed technology can be used as an adjunct to conventional angiographic procedures to provide important quantitative measurements of a blood vessel lumen.
Referring now to
The illustrated monitoring guidewire 102 can include several components, including a core wire 106 and one or more sensors 108 disposed in a distal region of the core wire 106. As used herein, the terms “distal” and “proximal” refer to physical directions within a blood vessel lumen. Specifically, in relation to the insertion point of a device into a patient, the term “distal” refers to the direction from the insertion point inwards into a blood vessel, and the term “proximal” refers to the direction from the inside of a blood vessel out towards the insertion point. As used herein, the terms “proximal” and “distal” can also refer to different ends of a device, with “proximal” being the end towards an insertion point into a blood vessel lumen and with “distal” being the end away from the insertion point.
With continuing reference to
In one embodiment, the communication unit 112 can employ wireless communication technology such as bluetooth, WiFi (802.11), or any other wireless technology. In one embodiment, the communication unit 112 can be a wireline communication unit that can include one or more wires for communicating electromagnetic signals and/or one or more optical fibers for communicating optical signals. The monitoring guidewire 102 can include other components that are not illustrated, such as a power source, A/D converters, application specific integrated circuits (ASIC), a processor, memory, timing circuitry, and/or other power, analog, or digital circuitry. Such components will be known to those skilled in the art.
Referring now to the illustrated portable display unit 104, the portable display unit 104 can include a display screen 114, one or more batteries 116, memory and/or storage 118, a communication unit 120, power management unit 122, and a processor 124. In one embodiment, the processor 124 can be a general purpose processor or can be an application specific integrated circuit. In one embodiment, the display screen 114 can be a liquid crystal display, an organic light emitting diode display, or another type of display technology. In one embodiment, the memory/storage 118 can include one or more of solid state memory/storage, magnetic disc storage, and/or any other type of memory/storage that will be known to those skilled in the art. In one embodiment, the memory/storage 118 can include software instructions that are executed by the processor 124. In one embodiment, the communication unit 120 can employ wireless communication technology such as bluetooth, WiFi (802.11), or any other wireless technology. In one embodiment, the communication unit 120 can be a wireline communication unit that can include one or more wires for communicating electromagnetic signals and/or one or more optical fibers for communicating optical signals. The portable display unit 104 can include other components that are not illustrated, such as user interface, operating system software, display driver circuitry, A/D converters, application specific integrated circuits (ASIC), timing circuitry, and/or other power, analog, or digital circuitry. Such components will be known to those skilled in the art.
Referring now to
Referring now to
In one embodiment, the connector connection establishes a communicative connection between the monitoring guidewire 402 and the portable display unit 400. The monitoring guidewire 402 and the connector 406 can contain electrical wires that connect the monitoring guidewire 402 to the portable display unit 400 and convey signals from the monitoring guidewire sensor(s) to the portable display unit 400.
In one embodiment, the connector connection establishes a mechanical connection between the monitoring guidewire 402 and the connector 406 to control the guidewire 402 within a vasculature. In the illustrated embodiment, the connector 406 is tethered to the main housing 410 of the portable display unit 400. In one embodiment, the tether can be 6 inches to 12 inches long and can allow a user to manipulate the monitoring guidewire 402 freely without the portable display unit main housing 410 being an impediment. In one embodiment, the tether can be another length. In one embodiment (not shown), the connector can be a connection port integrated in the portable display unit main housing 410.
In one embodiment, the connector 406 establishes a communicative connection with the monitoring guidewire 402. In one embodiment, a torquer (not shown) can be configured to engage the monitoring guidewire 402 to control the guidewire within a vasculature when the monitoring guidewire 402 is not mechanically and/or electrically connected to the connector 406. In one embodiment, the torquer can be configured to engage the monitoring guidewire 402 to control the guidewire within a vasculature when the monitoring guidewire 402 is mechanically and/or electrically connected to the connector 406. In one embodiment, the monitoring guidewire 402 does not need a torquer or the connector 406 for insertion into the vasculature of a patient and for navigation therein, and provides this capability by itself.
With continuing reference to
In the illustrated embodiment, the portable display unit 400 also includes a communication port 408. In one embodiment, the communication port 408 allows a user to connect the portable display unit 400 to an external system (not shown). The external system can communicate a sensor signal to the portable display unit 400 through the communication port 408. In one embodiment, the sensor signal received at the communication port can be can be a pressure measurement and can be used in calculating fractional flow reserve.
Referring again to
Referring to
Various aspects and embodiments of the disclosed technology have been described above. The illustrations and descriptions are merely exemplary and do not limit the scope of the disclosed technology. Even though not illustrated, various embodiments can be combined and are contemplated to fall within the scope of the disclosed technology. Furthermore, although certain features are illustrated as being in a particular location or device, the location and device are merely exemplary, and it is contemplated that various features can be located differently than as illustrated and still be within the scope of the disclosed technology.
The following description will now reference
In one embodiment, the predetermined duration can correspond to the approximate length of time of a single intravascular diagnosis procedure. In one embodiment, the predetermined duration can correspond to the approximate length of time of multiple diagnosis procedures, such as three procedures. In one embodiment, the predetermined duration can be twelve hours or twenty-four hours or several days. In one aspect of the disclosed technology, the portable display unit 104 can include one or more batteries 116 that are configured to power the portable display unit 104 for the desired duration, such that the batteries 116 are substantially depleted at the end of the desired duration. In one embodiment, the one or more batteries 116 are non-rechargeable, so that the portable display unit 104 is disposed after the batteries 116 are depleted. In one embodiment, the power management unit 122 can control the operating time of the portable display unit 104 by preventing the portably display unit 104 from powering down after the display screen 114 is turned on. In such an embodiment, the portable display unit 104 will operate continuously until the batteries 116 are depleted or substantially depleted. The portable display unit 104 can be disposed prior to the batteries 116 being depleted, while the portable display unit 104 is still operable.
In one embodiment, the portable display unit 104 can track the number of diagnosis procedures performed and can be configured to be inoperable after a particular number of procedures has been performed. In one embodiment, the portable display unit 104 can track the number of diagnosis procedures performed by the number of times the portable display unit 114 has been turned on and/or off. In one embodiment, the portable display unit 104 can be configured to be inoperable after a single diagnosis procedure has been performed. In one aspect of the disclosed technology, the power management unit 122 can prevent the portable display unit 104 from being powered on after the particular number of procedures has been reached. The batteries 116 can be rechargeable and can be recharged by a power source of the portable display unit 104 and/or by a power source external to the portable display unit 104. Even when the batteries 116 are not yet depleted, the power management unit 122 can cause the portable display unit 104 to be inoperable by preventing the batteries 116 from powering the portable display unit 104.
The intravascular diagnosis procedure will now be described with continuing reference to
The disclosed technology includes multiple ways of computing FFR, including what will be referred to herein as “push-forward FFR”, “pull-back FFR”, and “simultaneous FFR”. Each of these can be implemented by software code or machine code stored in memory/storage 118 of the portable display unit 104 (
Simultaneous Fraction Flow Reserve
Simultaneous FFR involves simultaneous pressure readings from two separate pressure sensors, and a computation of FFR in real-time as the pressure readings from the two separate pressure sensors are received. Referring to
Pport are moving means over time of real-time pressure measurements received at the communications port,
Psensor are moving means over time of real-time pressure measurements from the pressure sensor in the distal region of the core wire of the monitoring guidewire, and
Pra is a constant, which can be zero or another constant value.
In one embodiment, the moving means over time can compute the mean over a window of time that spans one heartbeat. In other embodiments, the window of time can span less than one heartbeat or more than one heartbeat. As new sensor measurements are received over time (902, 906), the window can include newer measurements and remove older measurements to compute the moving means.
The portable display unit 104 can receive pressure measurements and can compute the simultaneous FFR based on the received measurements. The portable display unit 104 can store the received pressure measurements and/or the computed simultaneous FFR in memory/storage 118, and can display the computed simultaneous FFR and/or a graph of the received pressure measurements on the display screen 114 (912).
Push-Forward Fractional Flow Reserve
In contrast to simultaneous FFR, the push-forward FFR does not receive external pressure measurements. With continuing reference to
Psaved are moving means over time of recorded pressure measurements proximal to the stenosis,
Psensor are moving means over time of real time pressure measurements distal to the stenosis, and
Pra is a constant, which can be zero or another constant value.
Aspects of computing the moving means over time were described above in connection with simultaneous FFR, and such aspects apply to push-forward FFR as well.
The portal display unit 104 can display the computed push-forward FFR and/or a graph of the received and stored pressure measurements (1012).
Push-forward FFR can be computed in the case of one stenosis and can also be computed in the case of multiple stenosis. In either case, Psaved are moving means over time of pressure measurements proximal to all of the stenosis. In one embodiment, Psaved are moving means over time computed based on recorded pressure measurements. In one embodiment, Psaved are moving means over time computed and recorded as pressure measurements are received, and the pressure measurements may or may not be recorded. For example, in the case of two stenoses, Psaved are based on pressure measurements proximal to both the first and second stenosis. When the monitoring guidewire pressure sensor 108 is pushed forward to a position between the first and the second stenosis, Psensor are based on real time pressure measurements between the two stenoses. Push-forward FFR can be calculated in this position and displayed on the display screen 114. When the monitoring guidewire pressure sensor 108 is pushed forward to a position distal to both the first and second stenoses, Psensor are based on real time pressure measurements distal to both of the two stenoses. Push-forward FFR can be calculated in this position and displayed on the display screen 114. Thus, push-forward FFR enables FFR to be computed and displayed as the monitoring guidewire 102 is pushed forward across one or more stenoses in a blood vessel lumen. The only measurements and/or moving means that need to be recorded for push-forward FFR computations are pressure measurements and/or moving means of pressure measurements proximal to all stenoses, and this is performed at the outset.
Pull-back Fractional Flow Reserve
Similar to push-forward FFR, the pull-back FFR does not receive external pressure measurements. Rather, pull-back FFR is computed using pressure measurements from only the pressure sensor(s) 108 in the distal region of the monitoring guidewire 102. Using traditional angiography, a stenosis can be located and, as shown in
FFR=(Psaved−Pra)/(Psensor−Pra)
where:
Psaved are moving means over time of recorded pressure measurements distal to the stenosis,
Psensor are moving means over time of real time pressure measurements proximal to the stenosis, and
Pra is a constant, which can be zero or another constant value.
Aspects of computing the moving means over time were described above in connection with simultaneous FFR, and such aspects apply to pull-back FFR as well.
The portal display unit 104 can display the computed pull-back FFR and/or a graph of the received and stored pressure measurements (1112).
Pull-back FFR can be computed in the case of one stenosis and can also be computed in the case of multiple stenosis. In either case, Psensor are based on real-time pressure measurements proximal to all of the stenosis, which are the final pressure measurements that are taken. For example, in the case of two stenoses, the monitoring guidewire pressure sensor 108 is initially placed at a position distal to both the first and the second stenoses. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104. In one embodiment, Psaved_d1 are moving means over time computed later based on recorded pressure measurements. In one embodiment, Psaved_d1 are moving means over time computed and recorded while the pressure measurements are received in this position, and the pressure measurements may or may not be recorded. The memory/storage 118 can record the pressure measurements in this position and/or computed moving means over time based on such pressure measurements. Pull-back FFR cannot yet be calculated because there is no real-time measurement yet proximal to all of the stenoses. Next, the monitoring guidewire 102 can be pulled back through the first stenosis to a point between the first and second stenosis. Pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104. In one embodiment, Psaved_d2 are moving means over time computed later based on recorded pressure measurements. In one embodiment, Psaved_d1 are moving means over time computed and recorded while the pressure measurements are received in this position, and the pressure measurements may or may not be recorded. The memory/storage 118 can record the pressure measurements in this position and/or computed moving means over time based on such pressure measurements. Once again, pull-back FFR cannot yet be calculated because there is no real-time measurement yet proximal to all of the stenoses. Lastly, the monitoring guidewire 102 can be pulled back through the second stenosis to a point proximal to both the first and second stenosis. Real-time pressure can be measured at this position by the sensor(s) 108 and communicated by the communication unit 112 to the portable display unit 104. Only at this point are there enough measurements to compute the two pull-back FFR: FFR1=(Psaved_d1−Pra)/(Psensor−Pra) and FFR2=(Psaved_d2−Pra)/(Psensor−Pra). Therefore, pull-back FFR does not allow FFR to be calculated and displayed as the monitoring guidewire is being pulled back through multiple stenoses.
Accordingly, three computations for fractional flow reserve have been described above in connection with
The disclosed technology measures pressure and calculates fractional flow reserve (FFR). FFR is a calculation that has been clinically demonstrated to assist in determining whether to treat or not to treat an intermediate coronary lesion. Using the disclosed technology will thus assist a physician in determining what to do with an intermediate lesion. The disclosed FFR equations are exemplary and do not limit the scope of the disclosed technology. Other ways to compute FFR are contemplated to be within the scope of the disclosed technology.
The illustrations, embodiments, and specifications disclosed herein are exemplary and do not limit the spirit and scope of the disclosed technology. Combinations of one or more disclosed embodiments or specification, or portions of one or more embodiments or specifications, are contemplated as being within the scope of the disclosed technology.
This application claims priority to U.S. Provisional Application No. 61/985,858, filed Apr. 29, 2014, and U.S. Provisional Application No. 61/841,517, filed Jul. 1, 2013. The entire contents of each and every priority application are hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
4691709 | Cohen | Sep 1987 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4867173 | Leoni | Sep 1989 | A |
4884579 | Engelson | Dec 1989 | A |
4901731 | Millar | Feb 1990 | A |
4928693 | Goodin et al. | May 1990 | A |
4936310 | Engstrom et al. | Jun 1990 | A |
4941473 | Tenerz et al. | Jul 1990 | A |
4953553 | Tremulis | Sep 1990 | A |
5040543 | Badera et al. | Aug 1991 | A |
5063935 | Gambale | Nov 1991 | A |
5065769 | de Toledo | Nov 1991 | A |
5113868 | Wise et al. | May 1992 | A |
5163445 | Christian et al. | Nov 1992 | A |
5178153 | Einzig | Jan 1993 | A |
5226421 | Frisbie et al. | Jul 1993 | A |
5226423 | Tenerz et al. | Jul 1993 | A |
5313957 | Little | May 1994 | A |
5358409 | Obara | Oct 1994 | A |
5412994 | Cook et al. | May 1995 | A |
5413508 | Obara | May 1995 | A |
5509411 | Littmann et al. | Apr 1996 | A |
5517989 | Frisbie et al. | May 1996 | A |
5549109 | Samson et al. | Aug 1996 | A |
5668320 | Cowan | Sep 1997 | A |
RE35648 | Tenerz et al. | Nov 1997 | E |
5685322 | Sung et al. | Nov 1997 | A |
5690120 | Jacobsen et al. | Nov 1997 | A |
5699796 | Littmann et al. | Dec 1997 | A |
5715827 | Corl et al. | Feb 1998 | A |
5779631 | Chance | Jul 1998 | A |
5797856 | Frisbie et al. | Aug 1998 | A |
5807265 | Itoigawa et al. | Sep 1998 | A |
5873835 | Hastings et al. | Feb 1999 | A |
5916177 | Schwager | Jun 1999 | A |
5938624 | Akerfeldt et al. | Aug 1999 | A |
6004279 | Crowley et al. | Dec 1999 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6089103 | Smith | Jul 2000 | A |
6106476 | Corl et al. | Aug 2000 | A |
6112598 | Tenerz et al. | Sep 2000 | A |
6142958 | Hammarstroem et al. | Nov 2000 | A |
6162182 | Cole | Dec 2000 | A |
6167763 | Tenerz et al. | Jan 2001 | B1 |
6183424 | Schwager | Feb 2001 | B1 |
6193669 | Degany et al. | Feb 2001 | B1 |
6196980 | Akerfeldt et al. | Mar 2001 | B1 |
6210339 | Kiepen et al. | Apr 2001 | B1 |
6248083 | Smith et al. | Jun 2001 | B1 |
6265792 | Granchukoff | Jul 2001 | B1 |
6312380 | Hoek et al. | Nov 2001 | B1 |
6336906 | Hammarstrom et al. | Jan 2002 | B1 |
6343514 | Smith | Feb 2002 | B1 |
6379308 | Brockway et al. | Apr 2002 | B1 |
6409677 | Tulkki | Jun 2002 | B1 |
6428336 | Akerfeldt | Aug 2002 | B1 |
6440088 | Jacobsen et al. | Aug 2002 | B1 |
6461301 | Smith | Oct 2002 | B2 |
6471656 | Shalman | Oct 2002 | B1 |
6565514 | Svanerudh et al. | May 2003 | B2 |
6579246 | Jacobsen et al. | Jun 2003 | B2 |
6615067 | Hoek et al. | Sep 2003 | B2 |
6615667 | Smith | Sep 2003 | B2 |
6672172 | Tulkki et al. | Jan 2004 | B2 |
6767327 | Corl et al. | Jul 2004 | B1 |
6779257 | Kiepen et al. | Aug 2004 | B2 |
6908442 | von Malmborg et al. | Jun 2005 | B2 |
6926674 | Tenerz et al. | Aug 2005 | B2 |
6976965 | Corl et al. | Dec 2005 | B2 |
7017420 | Kalvesten et al. | Mar 2006 | B2 |
7018346 | Griffin et al. | Mar 2006 | B2 |
7097620 | Corl et al. | Aug 2006 | B2 |
7134994 | Alpert et al. | Nov 2006 | B2 |
7263894 | Tenerz | Sep 2007 | B2 |
RE39863 | Smith | Oct 2007 | E |
7326204 | Paul et al. | Feb 2008 | B2 |
7450989 | Svanerudh | Nov 2008 | B2 |
RE40608 | Glover et al. | Dec 2008 | E |
7628763 | Noriega et al. | Dec 2009 | B2 |
7676910 | Kiepen et al. | Mar 2010 | B2 |
7706891 | Hastings et al. | Apr 2010 | B2 |
7711413 | Feldman et al. | May 2010 | B2 |
7774051 | Voth | Aug 2010 | B2 |
7775992 | von Malmborg et al. | Aug 2010 | B2 |
7857810 | Wang et al. | Dec 2010 | B2 |
7878981 | Strother | Feb 2011 | B2 |
7878984 | Jacobsen et al. | Feb 2011 | B2 |
7914466 | Davis et al. | Mar 2011 | B2 |
7931603 | Von Malmborg et al. | Apr 2011 | B2 |
7967761 | Smith | Jun 2011 | B2 |
7967762 | Corl et al. | Jun 2011 | B2 |
7988633 | Hossack et al. | Aug 2011 | B2 |
7988639 | Starks | Aug 2011 | B2 |
7998089 | Smith | Aug 2011 | B2 |
8012145 | Cawley | Sep 2011 | B2 |
8043312 | Noriega et al. | Oct 2011 | B2 |
8052683 | Podmore et al. | Nov 2011 | B2 |
8075490 | Lofgren et al. | Dec 2011 | B2 |
8105246 | Voeller et al. | Jan 2012 | B2 |
8162856 | Williams et al. | Apr 2012 | B2 |
8162934 | Potter | Apr 2012 | B2 |
8174395 | Samuelsson et al. | May 2012 | B2 |
8182466 | Stehr et al. | May 2012 | B2 |
8216151 | Smith | Jul 2012 | B2 |
8229545 | Afonso | Jul 2012 | B2 |
8231537 | Ahmed et al. | Jul 2012 | B2 |
8277386 | Ahmed et al. | Oct 2012 | B2 |
8317715 | Belleville et al. | Nov 2012 | B2 |
8340766 | Ryu et al. | Dec 2012 | B2 |
8343076 | Sela et al. | Jan 2013 | B2 |
8376991 | Kauphusman et al. | Feb 2013 | B2 |
8382689 | Sliwa et al. | Feb 2013 | B2 |
8391956 | Zellers et al. | Mar 2013 | B2 |
8403868 | Von Malmborg et al. | Mar 2013 | B2 |
8414568 | Harlan | Apr 2013 | B2 |
8419647 | Corl et al. | Apr 2013 | B2 |
8437832 | Govari et al. | May 2013 | B2 |
8468919 | Christian et al. | Jun 2013 | B2 |
8480636 | Khieu et al. | Jul 2013 | B2 |
8485985 | Manstrom et al. | Jul 2013 | B2 |
8551020 | Chen et al. | Oct 2013 | B2 |
8551021 | Voeller et al. | Oct 2013 | B2 |
8556914 | Vita | Oct 2013 | B2 |
8641633 | Smith | Feb 2014 | B2 |
8657789 | Guo et al. | Feb 2014 | B2 |
8684962 | Kirschenman et al. | Apr 2014 | B2 |
8684999 | Tegg et al. | Apr 2014 | B2 |
8696584 | Kassab | Apr 2014 | B2 |
8702613 | Kassab | Apr 2014 | B2 |
8734440 | Wu | May 2014 | B2 |
8734699 | Heideman et al. | May 2014 | B2 |
8755860 | Paul et al. | Jun 2014 | B2 |
8758333 | Harlan | Jun 2014 | B2 |
8764683 | Meller et al. | Jul 2014 | B2 |
8777929 | Schneider et al. | Jul 2014 | B2 |
8795254 | Layman et al. | Aug 2014 | B2 |
8818485 | Govari et al. | Aug 2014 | B2 |
8858591 | Preinitz et al. | Oct 2014 | B2 |
8915865 | Jacobsen et al. | Dec 2014 | B2 |
8936559 | Strommer et al. | Jan 2015 | B2 |
8979837 | de la Rama et al. | Mar 2015 | B2 |
8989849 | Milner et al. | Mar 2015 | B2 |
8998826 | Hauck et al. | Apr 2015 | B2 |
9301810 | Amiri et al. | Apr 2016 | B2 |
9326756 | Stangenes et al. | May 2016 | B2 |
20020072880 | Svanerudh | Jun 2002 | A1 |
20030023190 | Cox | Jan 2003 | A1 |
20030032886 | Dgany et al. | Feb 2003 | A1 |
20030069522 | Jacobsen et al. | Apr 2003 | A1 |
20030216621 | Alpert | Nov 2003 | A1 |
20040225232 | Malmborg et al. | Nov 2004 | A1 |
20050096566 | Amott | May 2005 | A1 |
20060052700 | Svanerudh | Mar 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060135864 | Westerlund | Jun 2006 | A1 |
20060211932 | Al-Ali | Sep 2006 | A1 |
20070010762 | Ressemann et al. | Jan 2007 | A1 |
20070078352 | Pijls | Apr 2007 | A1 |
20070185485 | Hauck et al. | Aug 2007 | A1 |
20070255144 | Tulkki et al. | Nov 2007 | A1 |
20070255145 | Smith et al. | Nov 2007 | A1 |
20070270741 | Hassett et al. | Nov 2007 | A1 |
20070299403 | Crowe et al. | Dec 2007 | A1 |
20070299424 | Cumming et al. | Dec 2007 | A1 |
20070299436 | Podmore et al. | Dec 2007 | A1 |
20070299438 | Holzbaur et al. | Dec 2007 | A1 |
20080091193 | Kauphusman et al. | Apr 2008 | A1 |
20080140101 | Carley et al. | Jun 2008 | A1 |
20080200773 | Pop | Aug 2008 | A1 |
20080221438 | Chen et al. | Sep 2008 | A1 |
20080221601 | Huynh et al. | Sep 2008 | A1 |
20080262474 | Northrop | Oct 2008 | A1 |
20090036832 | Skujins et al. | Feb 2009 | A1 |
20090171345 | Miller et al. | Jul 2009 | A1 |
20090177119 | Heidner et al. | Jul 2009 | A1 |
20100125197 | Fishel | May 2010 | A1 |
20100137736 | Addington et al. | Jun 2010 | A1 |
20100228112 | Von Malmborg | Sep 2010 | A1 |
20100234698 | Manstrom | Sep 2010 | A1 |
20100268038 | Smith | Oct 2010 | A1 |
20100305458 | Pfeiffer et al. | Dec 2010 | A1 |
20100318000 | Von Malmborg et al. | Dec 2010 | A1 |
20110004198 | Hoch | Jan 2011 | A1 |
20110009694 | Schultz | Jan 2011 | A1 |
20110054487 | Farnan | Mar 2011 | A1 |
20110152721 | Sela et al. | Jun 2011 | A1 |
20110160680 | Cage et al. | Jun 2011 | A1 |
20110160832 | Cohen | Jun 2011 | A1 |
20110178413 | Schmitt | Jul 2011 | A1 |
20120172731 | Smith | Jul 2012 | A1 |
20120278008 | Davies et al. | Nov 2012 | A1 |
20120289808 | Hubinette | Nov 2012 | A1 |
20130046190 | Davies | Feb 2013 | A1 |
20130046202 | Tsunezumi et al. | Feb 2013 | A1 |
20130076157 | Stein | Mar 2013 | A1 |
20130102927 | Hilmersson | Apr 2013 | A1 |
20130116579 | Svanerudh | May 2013 | A1 |
20130131523 | Suchecki et al. | May 2013 | A1 |
20130131663 | Govari et al. | May 2013 | A1 |
20130172782 | Hilmersson | Jul 2013 | A1 |
20130190633 | Dorando et al. | Jul 2013 | A1 |
20130218032 | Belleville | Aug 2013 | A1 |
20130237864 | Mazar et al. | Sep 2013 | A1 |
20130274618 | Hou et al. | Oct 2013 | A1 |
20130296692 | Vanney et al. | Nov 2013 | A1 |
20130296718 | Ranganathan et al. | Nov 2013 | A1 |
20130296722 | Warnking et al. | Nov 2013 | A1 |
20130317372 | Eberle et al. | Nov 2013 | A1 |
20130324842 | Mittal et al. | Dec 2013 | A1 |
20130338538 | Park et al. | Dec 2013 | A1 |
20140005558 | Gregorich | Jan 2014 | A1 |
20140039325 | Belleville | Feb 2014 | A1 |
20140058275 | Gregorich et al. | Feb 2014 | A1 |
20140058715 | Sharma et al. | Feb 2014 | A1 |
20140066790 | Burkett et al. | Mar 2014 | A1 |
20140066791 | Burkett | Mar 2014 | A1 |
20140081244 | Voeller et al. | Mar 2014 | A1 |
20140107624 | Belleville | Apr 2014 | A1 |
20140180028 | Burkett | Jun 2014 | A1 |
20140187979 | Burkett | Jul 2014 | A1 |
20140187983 | Anderson | Jul 2014 | A1 |
20140276109 | Gregorich | Sep 2014 | A1 |
20140276117 | Burkett | Sep 2014 | A1 |
20140276223 | Gustafsson | Sep 2014 | A1 |
20140276226 | Meller et al. | Sep 2014 | A1 |
20140336620 | Layman et al. | Nov 2014 | A1 |
20150032027 | Lupton | Jan 2015 | A1 |
Number | Date | Country |
---|---|---|
102202562 | Sep 2011 | CN |
0879615 | Nov 1998 | EP |
1125548 | Aug 2001 | EP |
1310215 | May 2003 | EP |
0877574 | Oct 2003 | EP |
0973438 | Nov 2003 | EP |
1433429 | Jun 2004 | EP |
1076511 | Aug 2004 | EP |
1125548 | Apr 2005 | EP |
0968547 | Aug 2005 | EP |
1012912 | Dec 2005 | EP |
0907335 | Sep 2006 | EP |
1837638 | Sep 2007 | EP |
1849409 | Oct 2007 | EP |
1055392 | Mar 2008 | EP |
1922988 | May 2008 | EP |
2042091 | Apr 2009 | EP |
1608418 | Jul 2009 | EP |
523337 | Apr 2004 | SE |
2001021057 | Mar 2001 | WO |
2003022122 | Mar 2003 | WO |
2009020836 | Feb 2009 | WO |
2011110817 | Sep 2011 | WO |
2012000798 | Jan 2012 | WO |
2012041905 | Apr 2012 | WO |
2012061935 | May 2012 | WO |
2012091783 | Jul 2012 | WO |
2012173697 | Dec 2012 | WO |
2013028737 | Feb 2013 | WO |
2013092969 | Jun 2013 | WO |
2013164682 | Nov 2013 | WO |
2013169451 | Nov 2013 | WO |
2014005095 | Jan 2014 | WO |
2014025255 | Feb 2014 | WO |
2014043704 | Mar 2014 | WO |
2014105578 | Jul 2014 | WO |
2014140883 | Sep 2014 | WO |
2014149688 | Sep 2014 | WO |
Entry |
---|
US 8,180,431 B2, 05/2012, Altmann et al. (withdrawn) |
Partial European Search Report issued in corresponding application No. 14820180 dated Jan. 10, 2017. |
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration issued in corresponding application No. PCT/US2016/037389 dated Sep. 27, 2016. |
B. Nudell, et al., “Fame II Good for FFR and PCI”, Credit Suisse Securities Research & Analytics, Americas/United States, Equity Research, Medical Supplies & Devices, Aug. 28, 2012, pp. 1-9. |
M. Weinstein, et al. “Cardiovascular Devices, FAME II: The Drumbeat of Data Supporting Broader FFR Use Continues”, J.P. Morgan North America Equity Research, Aug. 28, 2012 pp. 1-6. |
“PressureWire(TM) Certus(TM) with Agile Tip”, St. Jude Medical, 2012, pp. 1-2. |
S. Sen, et al., “Development and Validation of a New Adenosine-Independent Index of Stenosis Severity From Coronary Wave-Intensity Analysis”, Journal of the American College of Cardiology, vol. 59, No. 15, Apr. 10, 2012, pp. 1392-1402. |
R. Petraco et al., “Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry”, EuroIntervention 2013; 9: 91-101. |
De Bruyne et al, “Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease”, The New England Journal of Medicine, vol. 367, No. 11, Sep. 13, 2012, pp. 991-1001. |
“St. Jude Medical executive: FAMI II trial's FFR products showing ‘significant growth’”, http://medcitynews.com/2012/01/fame-ii-trials-ffr-products-showing-significant-growth-st- . . . Jan. 19, 2012. |
P. Tonino et al., “Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention”, The New England Journal of Medicine, vol. 360, No. 3, Jan. 15, 2009, pp. 213-224. |
R. Petraco et al., “Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation”, EuroIntervention 2013; 8:1157-1165. |
Written Opinion of the International Searching Authority issued in corresponding application No. PCT/US14/45171 dated Jan. 21, 2015. |
PCT International Search Report issued in corresponding application No. PCT/US2014/045171 dated Jan. 21, 2015. |
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013, PR Newswire—Thursday, May 23, 2013 (<http://m.yahoo.com/w/legobpengine/finance/news/volcano-announces-preliminary-results-advise-083000929.html?.intl=us&.lang=en-us>). |
Instructions for use PrimeWire Presige(R) Plus, Pressure Guide Wire, Models: 9185/9185J-9300/9300J English, Volcano, Aug. 2012. |
“Importance of FFR in Treatment of Coronary Artery Disease Confirmed by New PCI Guidelines”, St. Jude Medical News Release, Dec. 16, 2009, pp. 1-3. |
Instructions for Use for PressureWire(TM) Aeris (TM) Wireless FFR Measurement System, St. Jude Medical, Nov. 18, 2010. pp. 1-17. |
Instructions for Use for PressureWire(TM) Receiver, St. Jude Medical, Oct. 18, 2010, pp. 1-15. |
Quantien(TM) Integrated FFR Platform, St. Jude Medical, Jul. 10, 2013 (http://professional.sjm.com/products/vas/intravascular-diagnostics-imaging/ffr/quantien). |
Quantien(TM) Integrated FFR Platform, Dicom Conformance Statement Model Quantien—Cardiology, Revision A, St. Jude Medical, 2012, pp. 1-29. |
C. Berry et al., “VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in Every Practice)”, Journal of the American College of Cardiology, vol. 16, No. 13, 2013, pp. 1421-1427. |
“ADVISE Study Results Demonstrate the Instant Wave-Free Ratio (TM), a Vasodilate Free Measure of Stenosis Severity, is Comparable to FFR”, Volcano Corporation and Imperial College London Support Study Presented During Late Breaking Clinical Trial Session at TCT Nov. 14, 2011. |
Instructions for Use for “Combowire(R) Pressure/Flow Guide Wire Ref 9500 Series”, Volcano Corporation, Revision Date: Feb. 2012, pp. 1-4. |
Instructions for Use for “FloWire(R) Doppler Guide Wire Ref 1400 Series—FloWire”, Volcano Corporation, Revision Date Feb. 2012. |
Instructions for use for “PrimeWire PRESTIGE(R) Pressue Guide Wire”, Models: 8185/8185J-8300/8300J, Volcano Corporation, Revision Date Nov. 2012. |
Instructions for use for “PrimeWire PRESTIGE(R) Plus Pressure Guide Wire”, Models: 9185/9185J-9300/9300J, Volcano Corporation, Revision Date Aug. 2012. |
Instructions for use for “VERATTA(R) Pressue Guide Wire”, Models: 10185/10185J-10300/10300J, Volcano Corporation, Revision Date Jan. 2014. |
InvestorPlace, “Volcano, St. Jude: 2 hearts beat as one. The Companies dominate a potential $2 billion test market.” Jan. 14, 2013 (http://money.msn.com/top-stocks/post.aspx?post=3bb89ca7-9959-4173-910e-eee3fc37a742). |
J. Brosky, “Drug-free lesion assessment rivals fractional flow reserve”, Medical Device Daily, EuroPCR May 29, 2013 (http://www.medicaldevicedaily.com/servlet/com.accumedia.web.Dispatcher?next=bioWorl . . . ). |
Volcano Corporation S5/S5i (Chinese), www.dragonmedical.com, retrieved from internet Dec. 22, 2013. |
“Wi-Box(TM) Cath Lab Installation and FAQ Dec. 2011”, St. Jude Medical, 2011. |
“FFR and PressureWire(TM) Certus”, St. Jude Medical, p. 1-34, retrieved from Internet Feb. 9, 2014. |
“SJM PressureWire Certus IFU (2)”, St. Jude Medical, pp. 4-13, www.sjm.com, retrieved from internet Jun. 29, 2013. |
“SJM RadiAnalyzer IFU”, 20645 IFU RANXpress ENG R03 2010-12.indd, St. Jude Medical, pp. 3-48; 2010. |
“PressureWire(TM) Agile Tip Technology”, St. Jude Medical, p. 1-15; 2012. |
Extended European Search Report issued in corresponding application No. 14820180.9 dated Mar. 20, 2017. |
Chinese First Office Action issued in corresponding application No. 201480002922.4 dated Dec. 12, 2017. |
Australian Examination Report No. 1 for Australian Appln. No. AU 2014284381 dated Apr. 6, 2018 (3 pages). |
De Bruyne et al., “Coronary Flow Reserve Calculated From Pressure Measurements in Humans. Validation With Jositron Emission Tomography,” Circulation, Journal of the American Heart Association, Mar. 1994, vol. 89, No. 3, pp. 1013-1022. |
Allie et al., “Pressure-Sensing Guidewire Analysis in RAS,” Techniques, Endovascular Today, Oct. 2004, pp. 14-26. |
Australian Examination Report No. 2 for Australian Appln. No. AU 2014284381 dated Dec. 7, 2018 (3 pages). |
Examination Report issued by the Australian Patent Office dated Mar. 19, 2020 in corresponding Australian Patent Application No. 2016282495. |
Communication issued by the European Patent Office dated May 20, 2020 in corresponding European Patent Application No. 14820180.9. |
Number | Date | Country | |
---|---|---|---|
20150005648 A1 | Jan 2015 | US |
Number | Date | Country | |
---|---|---|---|
61985858 | Apr 2014 | US | |
61841517 | Jul 2013 | US |